Efficacy of Vibegron and Mirabegron for Overactive Bladder: A Systematic Literature Review and Indirect Treatment Comparison.

Michael J KennellyThomas RhodesCynthia J GirmanElizabeth ThomasDenise ShortinoPaul N Mudd

Published in: Advances in therapy (2021)

Vibegron was associated with significant improvement in total incontinence episodes versus mirabegron at 4 and 52 weeks and volume voided at 12 and 52 weeks. Improvement in micturitions was similar between vibegron and mirabegron or tolterodine. Incidence of AEs was generally comparable between vibegron and mirabegron.

Keyphrases

gestational age
risk factors
combination therapy
replacement therapy
smoking cessation